GPX4 and neoplasm: The administration of baicalein (10, 20 mg/kg, i.e., every two days for two weeks) significantly decreased the formation of tumors in a CRC xenograft mice model by blocking the JAK2/STAT3/GPX4 axis in tumor tissue.